Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 44 HER2-positive Breast Cancer 8 Carcinoma, Non-Small-Cell Lung 5 Breast Diseases 3 Brain Neoplasms 3 Advanced Breast Cancer 3 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Salivary Gland Neoplasms 1 Rare Tumour 1 Rare Tumor 1 Pathologic Complete Response 1 Non Small Cell Lung 1 Neoplasm Metastasis 1 Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1 Metastatic Breast Cancer in the Brain 1 Lung Neoplasms 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 HER2+ Early or Locally Advanced Breast Cancer 1 HER2 Positive Metastatic Breast Cancer 1 HER2 Positive Breast Cancer 1 HER2 Insertion Mutation Positive Advanced NSCLC 1 Estrogen Receptor-positive Breast Cancer 1 Esophageal Squamous Cell Carcinoma 1 Digestive System Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Breast Cancer Invasive 1

Interventions

Carboplatin 195 Cisplatin 117 Paclitaxel 107 Pemetrexed 106 Docetaxel 96 Gemcitabine 89 Radiotherapy 83 Erlotinib Hydrochloride 58 Bevacizumab 55 Etoposide 49 durvalumab 39 pembrolizumab 38 Nivolumab 31 Specimen Handling 30 Magnetic Resonance Spectroscopy 30 Irinotecan 27 Radiosurgery 26 osimertinib 24 Gefitinib 24 Drug Therapy 23 Vinorelbine 22 atezolizumab 20 Topotecan 20 Radiation 16 Cetuximab 16 Taxes 15 Surgical Procedures, Operative 14 Neoadjuvant Therapy 13 Filgrastim 13 Chemotherapy, Adjuvant 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lung Neoplasms × pyrotinib × Clear all

NCT06563999 2026-04-21

NUMER

Sun Yat-sen University

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡